Wright Lab Neurogenomics Research
Wright Lab Neurogenomics Research
Home
Tour
News
People
Publications
Funding
Winnipeg
Contact
2
Analyses of adverse drug reactions--nationwide active surveillance network: Canadian pharmacogenomics network for drug safety database
Reo Tanoshima
,
Amna Khan
,
Agnieszka K Biala
,
Jessica N Trueman
,
Britt I Drögemöller
,
Galen EB Wright
,
Jafar S Hasbullah
,
Gabriella SS Groeneweg
,
Colin JD Ross
,
Bruce C Carleton
,
others
Cite
Genome-Wide Association Studies of Drug-Induced Liver Injury Make Progress Beyond the HLA Region
Galen EB Wright
,
Britt I Drögemöller
,
Colin JD Ross
,
Bruce C Carleton
Cite
Glutaminase deficiency caused by short tandem repeat expansion in GLS
Andre BP van Kuilenburg
,
Maja Tarailo-Graovac
,
Phillip A Richmond
,
Britt I Drögemöller
,
Mahmoud A Pouladi
,
Rene Leen
,
Koroboshka Brand-Arzamendi
,
Doreen Dobritzsch
,
Egor Dolzhenko
,
Michael A Eberle
,
others
Cite
Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease
Galen EB Wright
,
Jennifer A Collins
,
Chris Kay
,
Cassandra McDonald
,
Egor Dolzhenko
,
Qingwen Xia
,
Kristina Bečanović
,
Britt I Drögemöller
,
Alicia Semaka
,
Charlotte M Nguyen
,
others
Cite
Outcome definition influences the relationship between genetic polymorphisms of ERCC1, ERCC2, SLC22A2 and cisplatin nephrotoxicity in adult testicular cancer patients
Zulfan Zazuli
,
Leila S Otten
,
Britt I Drögemöller
,
Mara Medeiros
,
Jose G Monzon
,
Galen EB Wright
,
Christian K Kollmannsberger
,
Philippe L Bedard
,
Zhuo Chen
,
Karen A Gelmon
,
others
Cite
Pharmacogenomics of Cisplatin-Induced Ototoxicity: Successes, Shortcomings, and Future Avenues of Research
Britt I Drögemöller
,
Galen EB Wright
,
Cody Lo
,
Tan Le
,
Beth Brooks
,
Amit P Bhavsar
,
Shahrad R Rassekh
,
Colin JD Ross
,
Bruce C Carleton
Cite
Pharmacogenomics of vincristine-induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes
Galen EB Wright
,
Ursula Amstutz
,
Britt I Drögemöller
,
Joanne Shih
,
Shahrad R Rassekh
,
Michael R Hayden
,
Bruce C Carleton
,
Colin JD Ross
,
Canadian Pharmacogenomics Network for Drug Safety Consortium
,
Henk Visscher
,
others
Cite
Common variation near IRF6 is associated with IFN-$β$-induced liver injury in multiple sclerosis
Kaarina Kowalec
,
Galen EB Wright
,
Britt I Drögemöller
,
Folefac Aminkeng
,
Amit P Bhavsar
,
Elaine Kingwell
,
Eric M Yoshida
,
Anthony Traboulsee
,
Ruth Ann Marrie
,
Marcelo Kremenchutzky
,
others
Cite
CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines
Britt I Drögemöller
,
Galen EB Wright
,
Joanne Shih
,
Jose G Monzon
,
Karen A Gelmon
,
Colin JD Ross
,
Ursula Amstutz
,
Bruce C Carleton
Cite
Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer PatientsThe Role of ACYP2 and WFS1 in Cisplatin-Induced Ototoxicity
Britt I Drögemöller
,
Beth Brooks
,
Carol Critchley
,
Jose G Monzon
,
Galen EB Wright
,
Geoffrey Liu
,
Daniel J Renouf
,
Christian K Kollmannsberger
,
Philippe L Bedard
,
Michael R Hayden
,
others
Cite
«
»
Cite
×